Invesaro

Stocks CNC Financial statements

Financial statements

CENTENE CORP financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data CENTENE CORP files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue40,60748,38260,11674,639111,115125,982144,547153,999163,071194,777
Cost of revenue1,8641,8472,3862,4653,3034,8947,0323,5642,7292,670
Gross profit38,74346,53557,73072,174107,81214,48716,91817,63717,06914,209
Selling, general and administrative3,6734,4466,0436,5339,3809,60111,58912,56312,40012,904
Operating income1,2631,1991,4581,7813,0821,7841,3182,9303,175-7,623
Interest expense217255343412728665665725702678
Other non-operating income6446681,082895
Pre-tax income1,1601,1341,3681,7822,7731,8131,9623,5984,257-6,728
Income tax599326474473979477760899963-51
Income from continuing operations559828
Net income to minority interests-1-20-6-12-14-110-3-11-3
Net income5628289001,3211,8081,3471,2022,7023,305-6,674
EBITDA1,5411,5601,9532,4244,3413,1192,7484,2234,416-6,348
EPS, basic1.762.402.313.193.172.312.094.976.33-13.53
EPS, diluted1.712.342.263.143.122.282.074.956.31-13.53
Shares, basic (weighted)319345390413571583575543522493
Shares, diluted (weighted)328353399420579591582546524493

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents3,9304,0725,34212,12310,80013,11812,07417,19314,06317,888
Short-term investments5055317228631,5801,5392,3212,4592,6222,432
Other current assets7156877841,0901,3171,6022,4615,5721,6011,945
Total current assets8,3658,70311,99820,32323,39328,49730,12840,75637,99940,370
Property, plant and equipment7971,1041,7062,1212,7743,3912,4322,0192,0672,037
Lease right-of-use assets6611,3113,5662,554396359317
Goodwill4,7124,7497,0156,86318,65219,77118,81217,55817,55810,835
Intangible assets1,5451,3982,2392,0638,3887,8246,9116,1015,4094,530
Long-term investments4,5455,3126,8617,71712,85314,04314,68416,28617,42917,035
Other non-current assets954545271,2491,5993,7812,686535593528
Total assets20,19721,85530,90140,99468,71978,37576,87084,64182,44576,747
Accounts payable3,7634,1654,0514,1647,0698,4939,52516,42013,17413,796
Deferred revenue313328385383523434478715661736
Short-term debt443888972678211911050
Total current liabilities8,6239,33211,97112,93221,58525,76528,46436,71634,26136,718
Long-term debt4,6514,6956,64813,63816,68218,57117,93817,71018,42317,351
Lease liabilities6221,3343,6193,133880738615
Other non-current liabilities8699521,2591,5432,9565,6105,6163,6182,5671,789
Total liabilities14,14314,97919,87828,30242,75751,35352,63358,68555,93556,691
Total debt4,7824,8296,85113,85916,88019,02618,17917,96218,64017,493
Paid-in capital4,1904,3497,4497,64719,45919,67220,06020,30420,56220,777
Retained earnings1,9202,7483,6634,9846,7928,1399,34112,04315,3488,674
Treasury stock-179-244-139-214-816-1,094-4,213-5,856-8,997-9,441
Other comprehensive income-36-3-5613433777-1,132-652-504-58
Shareholders' equity5,8956,85010,91712,55125,77326,79524,05725,84026,41019,953
Minority interests141496108112145124979080
Total equity5,9096,86411,01312,65925,88526,94024,18125,93726,50020,033
Total liabilities and equity20,19721,85530,90140,99468,71978,37576,87084,64182,44576,747
Shares outstanding172347412415581582551534496492

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income5618088941,3091,7941,3361,2022,6993,294-6,677
Depreciation and amortization2783614956431,2591,3351,4301,2931,2411,275
Stock-based compensation148135145177281203234216212204
Deferred income tax92-108-12955-51-132-631-7813-60
Change in payables40253-533-4215851,1414213,398-528-657
Cash from operations1,8511,4891,2341,4835,5034,2056,2618,0531545,088
Capital expenditures-306-422-675-730-869-910-1,004-799-644-767
Acquisitions-50-2,055-36-4,049-534-1,46000
Purchases of investments-2,432-2,656-3,846-2,575-7,402-7,400-6,736-6,622-7,183-4,541
Sales and maturities of investments1,5661,8621,9911,8094,9215,4583,8025,5235,7855,780
Cash from investing-2,469-1,254-4,585-1,532-6,955-3,299-2,921-1,191-1,052472
Debt issued8,9461,4006,07724,7215,1079,2673602,3351,300750
Debt repaid-6,076-1,353-4,083-17,803-4,067-7,434-1,490-2,316-622-1,895
Stock issued002,7790283570444637
Share buybacks-63-65-71-75-626-297-3,096-1,633-3,124-475
Cash from financing2,717-824,6126,8322601,362-4,197-1,658-2,406-1,621
Exchange rate effect-100-218-11-11-3280
Net change in cash2,0981531,2616,781-1,1742,257-8685,172-3,2963,939
Free cash flow1,5451,0675597534,6343,2955,2577,254-4904,321
Interest paid165237323374725658657688688647
Income taxes paid5564964486121,1916781,1988871,002448

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to September 30, 2026; growth uses fiscal years. Valuation uses the share price of $70.19 on November 10, 2026.

Profitability

MetricValueHow it is calculated
Gross margin7.9%Gross profit / revenue.
Operating margin0.5%Operating income / revenue.
EBITDA margin0.9%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin0.9%Pre-tax income / revenue.
Net margin0.7%Net income / revenue.
FCF margin1.9%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin2.3%Cash from operations / revenue.
Effective tax rate23.9%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)6.6%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)1.8%Net income / average total assets.
Return on invested capital (ROIC)4.5%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue6.4%Selling, general and administrative expense / revenue.
Stock-based pay / revenue0.1%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue0.4%Capital expenditures / revenue.
D&A / revenue0.4%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y19.4%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y10.5%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y11.9%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y-16.8%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y-5.7%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y-33.3%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y-340.1%Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y-243.8%EBITDA vs the same period a year earlier. Only from a positive base.
Net income growth, 1y-301.9%Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y-314.4%EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y3,204.0%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y-6.7%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y-1.6%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow CAGR, 3y-6.3%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y-1.4%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y-24.4%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y-6.0%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y-5.0%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y-6.9%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-0.1%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y2.2%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-5.8%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-5.4%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-3.2%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.16xCurrent assets / current liabilities.
Quick ratio0.60x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.60x(Cash + short-term investments) / current liabilities.
Debt / equity0.70xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets19.6%Total debt / total assets.
Liabilities / assets71.9%Total liabilities / total assets.
Net debt-$8.04BTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA-4.20xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage1.59xOperating income / interest expense.
Working capital$6.39BCurrent assets - current liabilities.
Goodwill and intangibles / assets18.8%(Goodwill + intangible assets) / total assets.
Tangible book value$7.33BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover2.57xRevenue / average total assets.
Fixed asset turnover96.7xRevenue / average property, plant and equipment.
Days payables2,025 days365 x average accounts payable / cost of revenue.
FCF conversion270.1%Free cash flow / net income, when net income is positive.
Capex / operating cash flow16.5%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$2.95Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$412.62Revenue / diluted weighted shares.
FCF per share$7.98Free cash flow / diluted weighted shares.
Operating cash flow per share$9.56Cash from operations / diluted weighted shares.
Book value per share$44.87Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$14.81Tangible book value / shares outstanding.
Cash per share$47.65(Cash + short-term investments) / shares outstanding.
Buybacks / FCF1.5%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$34.67BShare price x shares outstanding.
Enterprise value$26.63BMarket cap + total debt - cash - short-term investments.
P/E23.7xMarket cap / net income. Only when net income is positive.
P/S0.17xMarket cap / revenue.
P/B1.56xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book4.73xMarket cap / tangible book value, when positive.
P/FCF8.79xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF7.34xMarket cap / cash from operations, when positive.
EV/Sales0.13xEnterprise value / revenue.
EV/EBIT26.4xEnterprise value / operating income, when both are positive.
EV/EBITDA13.9xEnterprise value / EBITDA, when both are positive.
EV/FCF6.75xEnterprise value / free cash flow, when both are positive.
FCF yield11.4%Free cash flow / market cap.
Earnings yield4.2%Net income / market cap (the inverse of P/E).
Shareholder yield0.2%(Dividends paid + share buybacks) / market cap.
What was CENTENE CORP's revenue in fiscal 2025?

CENTENE CORP reported revenue of $194.78B for fiscal 2025, 19.4% higher than the year before.

Was CENTENE CORP profitable in fiscal 2025?

No. It reported a net loss of $6.67B.

How much free cash flow did CENTENE CORP generate in fiscal 2025?

Cash from operations of $5.09B minus capital expenditures of $767.0M left free cash flow of $4.32B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to CENTENE CORP